Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
29.35
+13.29 (+82.75%)
Official Closing Price
Updated: 4:15 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
Next >
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
Today 20:35 EST
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Via
Talk Markets
Why Abbvie Stock Popped Today
Today 19:19 EST
The company announces a major deal worth over $10 billion.
Via
The Motley Fool
Nasdaq Falls Over 100 Points; Cracker Barrel Shares Slide After Q1 Results
Today 14:12 EST
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Today 13:13 EST
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via
Benzinga
Health Care Company AbbVie Announces Acquisition of Immunogen
Today 10:10 EST
Via
Benzinga
Where Immunogen Stands With Analysts
November 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Today 12:31 EST
Via
Benzinga
Crude Oil Falls Sharply; Kroger Posts Upbeat Earnings
Today 12:16 EST
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal
Today 11:30 EST
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC)...
Via
Benzinga
Why Is Soligenix (SNGX) Stock Up 285% Today?
Today 11:07 EST
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.
Via
InvestorPlace
Exposures
Product Safety
Minim (MINM) Stock Soars 77% After Receiving Nasdaq Deficiency Notice
Today 10:52 EST
Minim stock is taking off with heavy trading of MINM shares on Thursday despite the company getting a delisting warning.
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About Immunogen
November 03, 2023
Via
Benzinga
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
Today 10:38 EST
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
Via
InvestorPlace
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
Today 10:32 EST
IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere.
Via
Investor's Business Daily
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
Today 10:12 EST
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October
Today 9:42 EST
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Today 8:06 EST
Via
Benzinga
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
Investors exposed to the biotech sector have seen mixed results this year.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
November 17, 2023
CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating
November 17, 2023
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.
Via
Investor's Business Daily
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 11, 2023
Via
Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
October 06, 2023
Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
These 8 Stocks Are Outperforming Nvidia In 2023
September 18, 2023
Carvana has surged 1,001%, leading huge winners this year.
Via
Investor's Business Daily
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
JP Morgan upgraded ImmunoGen Inc (NASDAQ: IMGN) from Neutral to Overweight with a price target of $22, up from $9, based on insights gathered from a recent physician survey, which focused on the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
September 13, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.